Loading…
Mass spectrometry analysis of circulating breast cancer cells from a Xenograft mouse model
Circulating tumor cells (CTCs) are precursors of metastasis in various cancer types. Many aspects regarding CTC biology remain poorly understood. Here, we describe mass spectrometric analysis of CTCs from a breast cancer xenograft mouse model, including procedures comprising CTC enrichment, separati...
Saved in:
Published in: | STAR protocols 2021-06, Vol.2 (2), p.100480-100480, Article 100480 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Circulating tumor cells (CTCs) are precursors of metastasis in various cancer types. Many aspects regarding CTC biology remain poorly understood. Here, we describe mass spectrometric analysis of CTCs from a breast cancer xenograft mouse model, including procedures comprising CTC enrichment, separation of different CTC subpopulations, and their quantitative proteomic assessment. This protocol aims to facilitate the identification of protein content dynamics in human CTCs that are physiologically shed from tumor-bearing xenografts, providing a framework for investigating metastasis biology.
For complete details on the use and execution of this protocol, please refer to Donato et al. (2020).
[Display omitted]
•Method for mass spectrometry analysis of circulating tumor cells from xenografts•Procedure to stain and separate subpopulations of circulating tumor cells•Methods to perform data analysis from mass spectrometry of circulating tumor cells
Circulating tumor cells (CTCs) are precursors of metastasis in various cancer types. Many aspects regarding CTC biology remain poorly understood. Here, we describe mass spectrometric analysis of CTCs from a breast cancer xenograft mouse model, including procedures comprising CTC enrichment, separation of different CTC subpopulations, and their quantitative proteomic assessment. This protocol aims to facilitate the identification of protein content dynamics in human CTCs that are physiologically shed from tumor-bearing xenografts, providing a framework for investigating metastasis biology. |
---|---|
ISSN: | 2666-1667 2666-1667 |
DOI: | 10.1016/j.xpro.2021.100480 |